Dyadic International

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYAI and other ETFs, options, and stocks.

About DYAI

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. 

CEO
Mark A. Emalfarb
CEOMark A. Emalfarb
Employees
6
Employees6
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
6
Employees6

DYAI Key Statistics

Market cap
28.73M
Market cap28.73M
Price-Earnings ratio
-4.78
Price-Earnings ratio-4.78
Dividend yield
Dividend yield
Average volume
83.03K
Average volume83.03K
High today
$1.23
High today$1.23
Low today
$0.92
Low today$0.92
Open price
$0.96
Open price$0.96
Volume
330.97K
Volume330.97K
52 Week high
$2.20
52 Week high$2.20
52 Week low
$0.912
52 Week low$0.912

DYAI News

TipRanks 8h
Dyadic International rebrands as Dyadic Applied BioSolutions

Dyadic International (DYAI) announced that, effective in 30 days, it will be doing business as Dyadic Applied BioSolutions, marking a pivotal step in the compan...

People also own

Based on the portfolios of people who own DYAI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.